Georgiadis C, Nickolay L, Syed F, Zhan H, Gkazi S, Etuk A
Haematologica. 2024; 109(12):3941-3951.
PMID: 38988258
PMC: 11609806.
DOI: 10.3324/haematol.2024.285101.
Cordon L, Chorao P, Martin-Herreros B, Montoro J, Balaguer A, Guerreiro M
Ann Hematol. 2024; 103(7):2475-2484.
PMID: 38634914
DOI: 10.1007/s00277-024-05758-0.
Borrill R, Poulton K, Wynn R
Front Pediatr. 2023; 11:1232281.
PMID: 37780051
PMC: 10534014.
DOI: 10.3389/fped.2023.1232281.
Horgan C, Mullanfiroze K, Rauthan A, Patrick K, Butt N, Mirci-Danicar O
Blood Adv. 2023; 7(10):2155-2165.
PMID: 36649566
PMC: 10206437.
DOI: 10.1182/bloodadvances.2022009253.
Baliu-Pique M, Tesselaar K, Borghans J
Front Immunol. 2022; 13:1059481.
PMID: 36483556
PMC: 9723355.
DOI: 10.3389/fimmu.2022.1059481.
Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival.
Martinez C, Aguayo-Hiraldo P, Chaimowitz N, Forbes L, Rider N, Nicholas S
Blood Adv. 2022; 7(9):1823-1830.
PMID: 36453638
PMC: 10165184.
DOI: 10.1182/bloodadvances.2022009038.
Cord blood power and the definition of success after BMT.
Boelens J, Scaradavou A
Blood Adv. 2022; 7(9):1811-1812.
PMID: 36350719
PMC: 10165175.
DOI: 10.1182/bloodadvances.2022009178.
Epstein-Barr Virus Reactivation After Paediatric Haematopoietic Stem Cell Transplantation: Risk Factors and Sensitivity Analysis of Mathematical Model.
Kania S, Silva J, Charles O, Booth J, Cheung S, Yates J
Front Immunol. 2022; 13:903063.
PMID: 35903096
PMC: 9314642.
DOI: 10.3389/fimmu.2022.903063.
TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined Immunodeficiency.
Tsilifis C, Lum S, Nademi Z, Hambleton S, Flood T, Williams E
J Clin Immunol. 2022; 42(4):851-858.
PMID: 35305204
PMC: 9166847.
DOI: 10.1007/s10875-022-01239-z.
Immune Reconstitution After Allogeneic Haematopoietic Cell Transplantation: From Observational Studies to Targeted Interventions.
Yanir A, Schulz A, Lawitschka A, Nierkens S, Eyrich M
Front Pediatr. 2022; 9:786017.
PMID: 35087775
PMC: 8789272.
DOI: 10.3389/fped.2021.786017.
Paving the Way for Immunotherapy in Pediatric Acute Myeloid Leukemia: Current Knowledge and the Way Forward.
Koedijk J, van der Werf I, Calkoen F, Nierkens S, Kaspers G, Zwaan C
Cancers (Basel). 2021; 13(17).
PMID: 34503174
PMC: 8431730.
DOI: 10.3390/cancers13174364.
Case Report: A Novel IL2RG Frame-Restoring Rescue Mutation Mimics Early T Cell Engraftment Following Haploidentical Hematopoietic Stem Cell Transplantation in a Patient With X-SCID.
Steininger J, Leiss-Piller A, Geier C, Rossmanith R, Elfeky R, Bra D
Front Immunol. 2021; 12:644687.
PMID: 33959125
PMC: 8093767.
DOI: 10.3389/fimmu.2021.644687.
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
Dholaria B, Labopin M, Sanz J, Ruggeri A, Cornelissen J, Labussiere-Wallet H
J Hematol Oncol. 2021; 14(1):76.
PMID: 33941226
PMC: 8094558.
DOI: 10.1186/s13045-021-01086-2.
Clinical Grade Production of Wilms' Tumor-1 Loaded Cord Blood-Derived Dendritic Cells to Prevent Relapse in Pediatric AML After Cord Blood Transplantation.
Plantinga M, Lo Presti V, de Haar C, Dunnebach E, Madrigal A, Lindemans C
Front Immunol. 2020; 11:559152.
PMID: 33101274
PMC: 7546401.
DOI: 10.3389/fimmu.2020.559152.
Immune Reconstitution in Pediatric Patients Following Hematopoietic Cell Transplant for Non-malignant Disorders.
Bhatt S, Bednarski J
Front Immunol. 2020; 11:1988.
PMID: 33013851
PMC: 7461808.
DOI: 10.3389/fimmu.2020.01988.
Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia.
Hiwarkar P, Adams S, Gilmour K, Nataraj R, Bonney D, Poulton K
Blood Adv. 2020; 4(17):4165-4174.
PMID: 32886752
PMC: 7479944.
DOI: 10.1182/bloodadvances.2020001737.
Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation.
Dekker L, de Koning C, Lindemans C, Nierkens S
Cancers (Basel). 2020; 12(7).
PMID: 32698396
PMC: 7409323.
DOI: 10.3390/cancers12071974.
TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.
Dasouki M, Jabr A, AlDakheel G, Elbadaoui F, Alazami A, Al-Saud B
Clin Exp Immunol. 2020; 202(1):60-71.
PMID: 32691468
PMC: 7488118.
DOI: 10.1111/cei.13484.
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis.
Xue E, Xie H, Leisenring W, Kimball L, Goyal S, Chung L
Clin Infect Dis. 2020; 72(8):1350-1357.
PMID: 32150265
PMC: 8075034.
DOI: 10.1093/cid/ciaa222.
Rapid reconstitution of regulatory T-cell subsets is associated with reduced rates of acute graft-versus-host disease and absence of viremia after cord blood transplantation in children with reduced-intensity conditioning using alemtuzumab.
Chen X, Hill M, Lugt M, Escolar M, Fang Z, Chen W
Cytotherapy. 2020; 22(3):149-157.
PMID: 32089448
PMC: 7263741.
DOI: 10.1016/j.jcyt.2020.01.005.